78 Biggest Movers From Friday

Gainers

• 908 Devices Inc. MASS shares surged 145% to close at $49.00 on Friday after the company priced its IPO at $20 per share.
• CURO Group Holdings Corp CURO jumped 88.7% to close at $16.59 on Friday. Katapult will go public through merger with FinServ Acquisition Corp. Katapult is 40% owned by CURO Group.
• Mereo BioPharma Group plc MREO shares surged 62.9% to close at $3.60. Mereo BioPharma and Ultragenyx announced a license and collaboration agreement for setrusumab, a monoclonal antibody in clinical development for osteogenesis imperfecta.
• FG Financial Group, Inc. FGF gained 51% to close at $4.68.
• Vistagen Therapeutics Inc VTGN surged 46.9% to close at $1.36 after gaining 11% on Thursday. VistaGen priced its 63 million share common stock offering at $0.92 per share.
• FinServ Acquisition Corp. FSRV gained 36.4% to close at $14.25. Katapult would go public through merger with FinServ Acquisition Corp.
• FireEye, Inc. FEYE jumped 33.7% to close at $19.23.
• Organovo Holdings, Inc. ONVO gained 29.3% to close at $10.28.
• Presidio Property Trust, Inc. SQFT shares surged 28.9% to close at $4.77 on Friday after jumping over 26% on Thursday.
• Deerfield Healthcare Technology Acquisitions Corp. DFHT rose 27.4% to close at $14.35 after the company reported a proposal of a business combination to form CareMax.
• BEST Inc. BEST surged 26.3% to close at $2.59.
• Exela Technologies, Inc. XELA gained 26.1% to close at $0.4576 as the company secured a term loan of $145 million.
• AgEagle Aerial Systems, Inc. UAVS jumped 25.8% to close at $4.05.
• Vuzix Corporation VUZI climbed 24.8% to close at $8.31.
• 9 Meters Biopharma, Inc. NMTR shares climbed 24.7% to close at $1.01. 9 Meters Biopharma shares climbed over 7% on Thursday after OrbiMed Israel BioFund GP Limited Partnership reported a 16% stake in the company.
• Upstart Holdings, Inc. UPST gained 23.3% to close at $44.09 after climbing 21% on Thursday. Upstart priced its IPO at $20 per share.
• Nymox Pharmaceutical Corporation NYMX rose 23% to close at $2.83.
• China Green Agriculture, Inc. CGA gained 22.8% to close at $2.88.
• Evelo Biosciences, Inc. EVLO rose 21.6% to close at $11.59.
• Tenable Holdings, Inc. TENB jumped 21.1% to close at $51.85.
• Origin Agritech Limited SEED gained 20.6% to close at $13.87.
• Elys Game Technology Corp ELYS shares climbed 19.7% to close at $4.26 after declining 9% on Thursday.
• Nemaura Medical Inc. NMRD gained 19.5% to close at $4.35.
• Sonoma Pharmaceuticals Inc SNOA surged 19% to close at $9.08 after the company reported a partnership with Gabriel Science for dental markets.
• Qualys, Inc. QLYS gained 18.7% to close at $124.54.
• Digital Media Solutions, Inc. DMS surged 18.6% to close at $11.13. BTIG, last week, initiated coverage on the stock with a Buy rating and announced a price target of $15 per share.
• 4D Molecular Therapeutics, Inc. FDMT jumped 18.5% to close at $47.36. 4D Molecular Therapeutics, on December 11, priced its IPO at $23 per share.
• Cyclo Therapeutics, Inc. CYTH gained 17.9% to close at $5.59. Cyclo Therapeutics shares jumped 23% on Thursday after Maxim Group initiated coverage on the stock with a Buy rating and a price target of $12 per share.
• Earthstone Energy, Inc. ESTE surged 17.7% to close at $4.92 after the company acquired Independence Resources Management for roughly $185.9 million.
• Precigen, Inc. PGEN gained 17.6% to close at $9.63. Precigen, earlier during the month, presented new data supporting safety, clinical activity, expansion, persistence of PRGN-3006 UltraCAR-T at the ASH.
• C3.ai, Inc. AI climbed 17.4% to close at $137.59.
• BioTelemetry, Inc. BEAT surged 16.9% to close at $72.22 after Royal Philips announced plans to buy for $72.00 per share.
• Magnite, Inc. MGNI jumped 16.9% to close at $23.25 after Susquehanna initiated coverage on the stock with a Positive rating and announced a $30 price target.
• CyberArk Software Ltd. CYBR gained 16.3% to close at $145.08.
• Progenity, Inc. PROG surged 16.2% to close at $6.32. Progenity, last week, said it is expanding the availability of its COVID-19 RT-PCR Testing across the US.
• Flux Power Holdings, Inc. FLUX gained 15.7% to close at $13.04 as the company reported three patents pending for advanced lithium-ion battery technology.
• CNS Pharmaceuticals, Inc. CNSP climbed 15.6% to close at $2.89.
• Avenue Therapeutics, Inc. ATXI gained 15.4% to close at $6.29.
• Clean Energy Fuels Corp. CLNE surged 15.3% to close at $5.50.
• GTY Technology Holdings Inc. GTYH climbed 14.5% to close at $4.50. Craig-Hallum initiated coverage on GTY Technology with a Buy rating and announced a price target of $6.
• Fathom Holdings Inc. FTHM gained 14.3% to close at $35.82.
• Sunworks, Inc. SUNW surged 11% to close at $4.84. Sunworks, earlier during the month, announced it used a portion of proceeds from a stock sale to repay the outstanding balance under a loan agreement with CrowdOut Capital.
• Humanigen, Inc. HGEN climbed 10.5% to close at $15.51. Humanigen shares climbed around 24% on Thursday after the company reported completion of enrollment in Phase 1 study of Ifabotuzumab in Glioblastoma Multiforme.
• JinkoSolar Holding Co., Ltd. JKS rose 10.1% to close at $65.25. JinkoSolar recently announced at-the-market offering of ADSs up to $10 million of ADS.
• Tattooed Chef, Inc. TTCF shares gained 9.4% to close at $22.16 after gaining over 5% on Thursday. Tattooed Chef, last week, reported the expansion of its product range with meat alternatives.
• DermTech Inc DMTK gained 8.3% to close at $15.49 after the company disclosed topline results from TRUST study.
• Amyris, Inc. AMRS gained 7.1% to close at $4.37.
• Team, Inc. TISI rose 6.8% to close at $11.00 as the company reported refinancing of new capital structure.
• Surface Oncology, Inc. SURF gained 6.2% to close at $9.04. Surface Oncology, on Thursday, announced an agreement for GlaxoSmithKline to exclusively license worldwide development and commercial rights to its preclinical program SRF813, an inhibitory protein expressed on natural killer cells and T cells, for an $85-million upfront payment.
• Eloxx Pharmaceuticals, Inc. ELOX gained 5.6% to close at $4.16 following a 30% surge on Thursday.

Check out these big penny stock gainers and losers

Losers

• Virios Therapeutics, LLC VIRI shares declined 37.8% to close at $10.40. Virios Therapeutics shares jumped 67% on Thursday as the company priced its IPO at $10 per share.
• Scopus BioPharma Inc. SCPS fell 36.5% to close at $21.55 after climbing 474% on Thursday. Scopus BioPharma’s filing showed registration for 500,000 share common stock offering. Scopus Biopharma priced its IPO at $5.5 per share.
• Wunong Net Technology Company Limited WNW fell 36.3% to close at $77.98 after surging 88% on Thursday. The company, on Tuesday, priced its IPO at $5 per share.
• MingZhu Logistics Holdings Limited YGMZ shares dipped 35.8% to close at $11.24 on Friday after jumping 336% on Thursday.
• Mesoblast Limited MESO shares fell 31.7% to close at $9.27. Mesoblast said Data Safety Monitoring Board that performed a third interim analysis of data from a study of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory distress syndrome due to COVID-19 infection said the trial is not likely to meet the 30-day mortality reduction endpoint at the planned 300 patient enrolment.
• Fuel Tech, Inc. FTEK fell 21.1% to close at $3.18.
• SolarWinds Corporation SWI tumbled 19.4% to close at $14.18. Microsoft said Thursday it had found “malicious” binaries in its environment related to the breach that affected the United States Treasury and SolarWinds.
• Frequency Therapeutics, Inc. FREQ fell 19% to close at $32.14.
• AlloVir, Inc. ALVR dipped 18.4% to close at $35.77. AlloVir, last week, reported the FDA clearance of investigational New Drug Application for ALVR106, an allogeneic, off-the-shelf, multi-virus specific T cell therapy targeting four devastating respiratory viruses.
• Oriental Culture Holding LTD OCG dropped 18.1% to close at $6.00 after gaining 20% on Thursday. Oriental Cultural, on Tuesday, priced its IPO at $4 per share.
• Nurix Therapeutics, Inc. NRIX fell 18% to close at $36.01.
• Applied DNA Sciences Inc APDN dropped 17.3% to close at $5.16 after the company reported downbeat quarterly results.
• BioCardia, Inc. BCDA fell 16.6% to close at $3.56. BioCardia shares tumbled 26% on Thursday after the company announced that the independent Data Safety Monitoring Board has completed its prespecified data review for the Phase III pivotal CardiAMP Heart Failure Trial.
• BlackBerry Limited BB fell 15.9% to close at $6.95. BlackBerry reported upbeat earnings for its third quarter, posting an adjusted profit of $0.02 per share, versus analysts’ estimates for a loss of $0.01 per share.
• Vivos Therapeutics, Inc. VVOS fell 15.5% to close at $7.70 after gaining 34% on Thursday. Vivos Therapeutics, earlier during the month, priced its IPO at $6 a share.
• Greenwich LifeSciences, Inc. GLSI fell 14.2% to close at $38.22 after the company priced 660,000 share common stock offering at $40 per share.
• Zhongchao Inc. ZCMD declined 13.8% to close at $1.81.
• Arcadia Biosciences, Inc. RKDA declined 13.7% to close at $2.53 after the company announced a $8 million registered direct offering priced at-the-market.
• EVI Industries, Inc. EVI dropped 13.1% to close at $29.08.
• Aethlon Medical, Inc. AEMD fell 11.2% to close at $2.07. Aethlon Medical, earlier during the week, said it treated the first patient in its first-in-human Early Feasibility Study of the HEMOPURIFIER.
• TuanChe Limited TC dropped 10.5% to close at $6.35 following Q3 results.
• CalAmp Corp. CAMP dropped 10.2% to close at $9.69. JP Morgan downgraded CalAmp from Neutral to Underweight.
• Neovasc Inc. NVCN fell 10.1% to close at $0.8940. Neovasc, on Thursday, highlighted publication of peer-reviewed article in EuroIntervention.
• Scholastic Corp SCHL declined 9.8% to close at $24.28 after reporting downbeat Q2 results.
• Boqii Holding Limited BQ fell 9.3% to close at $6.35 after climbing 46% on Thursday.
• United States Steel Corporation X fell 9.1% to close at $16.87 after the company issued weak earnings forecast for the fourth quarter. The company said it sees Q4 adjusted loss of $0.85 per share.
• Triterras, Inc. TRIT fell 7% to close at $8.45. Triterras shares tumbled 31% on Thursday after confirming it informed a statutory demand for payment was made to Antanium Resources in Singapore. Triterras said in a regulatory filing it was informed that a statutory demand for payment from Antainium Resources (formerly known as Rhodium Resources) was filed by a creditor of Rhodium on Dec. 1.
• FedEx Corporation FDX shares fell 5.7% to close at $275.57. FedEx reported better-than-expected second-quarter results, but did not provide guidance for 2021.